Who is sponsoring NCT04992741?

NCT04992741 is sponsored by Yasemin ATEŞEYAN.

What drugs are being tested in NCT04992741?

Interventions in NCT04992741: education and motivational interview.

What condition does NCT04992741 study?

NCT04992741 studies HPV VACCINATION.

Is NCT04992741 still recruiting?

NCT04992741 is currently completed. Last updated 5 August 2021.

Last reviewed 2021-08-05 · How we verify

NCT04992741

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Health Belief Model-based Education and Motivational Interview Regarding the HPV Vaccination Decision

Completed NA Last updated 5 August 2021

What this trial tests

NA trial testing education and motivational interview in HPV VACCINATION in 63 participants. Completed in 15 June 2021.

Timeline

1 September 2020

Primary endpoint
1 January 2021

15 June 2021

Quick facts

Lead sponsor	Yasemin ATEŞEYAN
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	single
Primary purpose	supportive care
Enrollment	63
Start date	1 September 2020
Primary completion	1 January 2021
Estimated completion	15 June 2021
Sites	1 location across Turkey (Türkiye)

Drugs / interventions tested

education and motivational interview

Conditions studied

HPV VACCINATION — all drugs for HPV VACCINATION →

Sponsor

Yasemin ATEŞEYAN

Who can join

Eligibility, female only, with HPV VACCINATION. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This research is a single-blind, randomized, parallel-controlled experimental study designed to determine the effect of Health Belief Model (SIM)-based motivational interviews given to mothers of high school students on mothers' knowledge, beliefs and attitudes towards HPV vaccine. . The hypotheses of the research; The experimental group that received training and motivational interviews within the framework of SIM had higher knowledge and perception of HPV infection and vaccination in the posttest than the control group that did not receive any application.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Web and theory-based motivational interviews in encouraging mothers for HPV vaccination of their daughters: A randomized controlled study.
Ateşeyan Y, Güngörmüş Z. · · 2024 · PMID 39060172 · DOI 10.1016/j.pedn.2024.07.016

Verify or expand the search:

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04992741 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Yasemin ATEŞEYAN
Last refreshed: 5 August 2021

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04992741.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing